Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma
暂无分享,去创建一个
Jian Yu | John Rush | Yi Wang | Gang Deng | Zhiping Tan | J. Nardone | J. Rush | T. Gu | Xinmin Zhou | Jian Yu | M. Comb | C. Peng | Hongwei Li | K. Crosby | Yi Wang | J. Macneill | J. Ren | H. Haack | C. Reeves | Ye-rong Hu | Zhiping Tan | Jin Yuan | Xiaxing Deng | Baiyong Shen | Feizhou Huang | Julie Nardone | Hongwei Li | V. Rimkunas | Chenghong Peng | Katherine Crosby | Jianmin Ren | Michael J. Comb | Ting-Lei Gu | Xiaxing Deng | Feizhou Huang | Meghan Tucker | Victoria Rimkunas | Lei Zhu | Yerong Hu | Chunlin Wu | Joan MacNeill | Cynthia Reeves | Gregory Innocenti | Brett Norris | Jin Yuan | Herbert Haack | Baiyong Shen | Xinmin Zhou | Xunyang Liu | G. Deng | M. Tucker | Chunlin Wu | Lei Zhu | Xunyang Liu | Gregory Innocenti | B. Norris | Jian Yu | Chenghong Peng | Joan Macneill
[1] Ronald A. DePinho,et al. Hepatocellular carcinoma pathogenesis: from genes to environment , 2006, Nature Reviews Cancer.
[2] T. Hunter,et al. Oncogenic kinase signalling , 2001, Nature.
[3] Keara M. Lane,et al. Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas. , 2009, Cancer research.
[4] A. Han,et al. RHEB expression in fibroadenomas of the breast , 2008, Pathology international.
[5] Keara M. Lane,et al. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. , 2006, Cancer research.
[6] Peter G. Schultz,et al. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK , 2007, Proceedings of the National Academy of Sciences.
[7] J. Figueras,et al. Biliary tract cancers. , 2000, The New England journal of medicine.
[8] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[9] Laura A. Sullivan,et al. Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer , 2007, Cell.
[10] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[11] Keara M. Lane,et al. Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21) , 2003, Genes, chromosomes & cancer.
[12] N. London,et al. Liver transplantation for malignancy. , 1991, British Journal of Cancer.
[13] J. Rush,et al. A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia. , 2007, Blood.
[14] J. Fujimoto,et al. Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings. , 2008, Journal of hepatology.
[15] J. Acquaviva,et al. The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. , 2009, Biochimica et biophysica acta.
[16] G. Gores,et al. Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment , 2008, Hepatology.
[17] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[18] S. Thorgeirsson,et al. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Rush,et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells , 2005, Nature Biotechnology.
[20] Keara M. Lane,et al. Association of a Novel PDZ Domain-containing Peripheral Golgi Protein with the Q-SNARE (Q-solubleN-Ethylmaleimide-sensitive Fusion Protein (NSF) Attachment Protein Receptor) Protein Syntaxin 6* , 2001, Journal of Biological Chemistry.
[21] Keara M. Lane,et al. Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] Natalie I. Tasman,et al. A guided tour of the Trans‐Proteomic Pipeline , 2010, Proteomics.